Welcome to JEmedis
JEmedis. Our team. Our mission.
JEmedis is a great, young company. Small, flexible and above all innovative.
Our team
JEmedis has a highly competent team at its disposal, committed team, where you benefit from short decision-making paths so that processes can be implemented quickly and easily. We combine our specialist know-how with many years of experience.
Our mission
In addition to our already established and proven drug
for the treatment of
bladder cancer
we are further expanding our portfolio for our patients and customers. JEmedis is currently developing another product for this indication.
In the CDMO area, our customers benefit from from our expertise in innovative product development, which we incorporate into our customers’ projects and transfer into customized processes. This enables us to provide you with sustainable support in optimizing and accelerating production steps and reducing risks.
Innovative active ingredient development at JEmedis
TEAMWORK is a top priority at JEmedis. We attach great importance to our employees’ ability to cooperate. In this way, we transfer the expertise and competence we have built up over many years to projects, products and new team members. This gives our employees a wide range of specialized knowledge in many areas, enabling them to accompany all processes from start to finish.
Our history
JEmedis is a young company that was founded in 2021. However, it can draw on decades of experience in the pharmaceutical sector, as it emerged from PharmaCept GmbH in Luckenwalde. PharmaCept GmbH was founded in Berlin in 1998 and specializes in the marketing of medicinal products and medical devices in the urological/oncological field. In order to further expand the portfolio, we pursued the vision of developing our own drug in this area.
Foundation of JEmedis GmbH from PharmaCept GmbH — Luckenwalde site
Start of development as CDMO
Obtaining GMP approval and manufacturing authorization
Composition of the team
Construction of our own production facility at the Luckenwalde Biotechnology Park
To this end, the company set up its own production facility at the Luckenwalde Biotechnology Park in 2015. From then on, the team worked on developing the plant into a cGMP-compliant production facility. After 23 years of successful management of PharmaCept GmbH, the company was sold in parts. JEmedis GmbH was founded from the Luckenwalde site.